Ładuje się......
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
During the natural history of chronic hepatitis B virus (HBV) infection, the loss of serum hepatitis B e antigen (HBeAg) and the development of anti-HBe antibodies (HBeAg seroconversion) mark a transition from the immune-active phase of disease to the inactive carrier state. This review examines the...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer-Verlag
2009
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2748370/ https://ncbi.nlm.nih.gov/pubmed/19669245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-009-9140-3 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|